Christopher Houck is a Neurology physician. OpenAlex indexes 71 publications with 1,915 citations (h-index 25); ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
660 S Euclid Ave
Saint Louis, MO 631101010
Telephone
843-301-1911Provider last certified this registry record 2 Jul 2024.
Clinical trials
- An Interactive Education Program to Reduce High Risk Behavior in Adolescents Ph II (iTRAC HERO)
Sponsor: Klein Buendel, Inc.
- Education Program to Reduce Risky Behavior in Adolescents Ph I
Sponsor: Klein Buendel, Inc.
- An Emotion Regulation Intervention for Early Adolescent Risk Prevention
Sponsor: Rhode Island Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Other antiepileptics40%Levetiracetam100%Part D<11 patientsAromatic Amino Acid Decarboxylation Inhibitor30%Carbidopa-Levodopa100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Pilot Study of a Tablet-Based Emotion Regulation Intervention for Early Adolescents
Journal of Developmental & Behavioral Pediatrics
2022 - Sexting as a Predictor of First-Time Sexual Behavior Among At-Risk Early Adolescents
The Journal of Early Adolescence
2022 - Perceived Strengths and Difficulties in Emotional Awareness and Accessing Emotion Regulation Strategies in Early Adolescents
Journal of Child and Family Studies
2022 - Causally Interpretable Meta-analysis: Application in Adolescent HIV Prevention
Prevention Science
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”